Sirona SRL
0.5 FTESirona reported total assets of 126,289 € at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Apr 2026), with 0.5 full-time equivalent.
The score of Sirona shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -19 % Total assets -25 % Headcount (avg FTE) -44 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sirona's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 21,812 € | ||||
| Equity | 18,534 € | ||||
| Cash | 14,113 € | ||||
| EBITDA | 33,784 € | ||||
| Total assets | 126,289 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Apr 2026
- Year ended 31 Dec 2024filed on 09 May 2025
- Year ended 31 Dec 2023filed on 02 Aug 2024
- Year ended 31 Dec 2022filed on 25 May 2023
- Year ended 31 Dec 2021filed on 26 May 2022
Sirona's financial analysis
- Solvency14.7%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sirona
Sirona's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0762.741.682
- VAT number
- BE0762741682
- Peppol
- Registered · 0208:0762741682 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Feb 2021
- Registered office
- 1040 Etterbeek
- Size
- Micro · 0.5 FTE
- Latest accounts
- 2025 · filed on 01 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sirona (SRL) has been based in Etterbeek since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 21,812 € and equity of 18,534 €; its revenue is not published. With 0.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 14.7%, below the median of its sector (37.8%).
Companies similar to Sirona
Companies in the same business, of comparable size and area, outside its group.
- Mont Royal Retail sale of pharmaceutical products Brussels · balance sheet 126,135 €
- Pharmacie VERHEYDEN Retail sale of pharmaceutical products Brussels · balance sheet 135,673 €
- Pharma Nasir Retail sale of pharmaceutical products Ixelles · balance sheet 126,608 €
- Apotheker Kaat Stas Retail sale of pharmaceutical products Mortsel · balance sheet 123,434 €
- O.Sabur Retail sale of pharmaceutical products Genk · balance sheet 129,423 €
- Medlinx Lina Retail sale of pharmaceutical products Schaerbeek · balance sheet 130,245 €
- Toelen Apotekers Retail sale of pharmaceutical products Halle · balance sheet 118,845 €
- Farma Jana Retail sale of pharmaceutical products Lo-Reninge · balance sheet 118,424 €
Frequently asked questions about Sirona
What is the revenue of Sirona?
Sirona files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sirona?
In Belgium, the VAT number is the company number prefixed with BE: BE0762741682 for Sirona, if the company is VAT-registered. Its company number (CBE) is 0762.741.682.
Where is the registered office of Sirona?
According to the CBE register, the registered office of Sirona is in 1040 Etterbeek.
What is the equity of Sirona?
At the close of the 2025 financial year, the equity of Sirona amounts to 18,534 €, a solvency of 14.7% of total assets.
How many people work at Sirona?
0.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sirona?
The register lists 2 active mandates at Sirona. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sirona
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →